Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1328-1337

  Engele, Matthias ^a   Stößel, Elmar ^a   Castiglione, Kirstin ^a   Schwerdtner, Nives ^a   Wagner, Manfred ^a   Bölcskei, Pal ^a   Röllinghoff, Martin ^a   Stenger, Steffen ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIAL REPRODUCTION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; GRANULOMA; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0036467358     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1328     Document Type: Article

References (75)

1. Tumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors
2. Control of Leishmania major infection in mice lacking TNF receptors
3. TNF receptors in murine Candida albicans infection: Evidence for an important role of TNF receptor p55 in antifungal defense
4. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
5. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
6. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
7. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
8. Anti-TNFα therapy of rheumatoid arthritis: What have we learned?
9. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum
10. Thalidomide treatment reduces tumor necrosis factor α production and enhances weight gain in patients with pulmonary tuberculosis
11. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice
12. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis
13. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients
14. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection
15. Restraining mycobacteria: Role of granulomas in mycobacterial infections
16. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components
17. Role of monocyte chemoattractant protein-1 in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production
18. Interleukin-8 induces lymphocyte chemotaxis into the pleural space: Role of pleural macrophages
19. An antimicrobial activity of cytolytic T cells mediated by granulysin
20. Lifetime risks, incubation period, and serial interval of tuberculosis
21. Immune responses in tuberculosis
22. Activation of tuberculostatic macrophage functions by γ interferon, interleukin-4, and tumor necrosis factor
23. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice
24. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
25. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
26. Immunopathologic effects of tumor necrosis factor α in murine mycobacterial infection are dose dependent
27. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis
28. Selective increase in plasma tumor necrosis factor-α and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis
29. Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
30. Reactivation tuberculosis in a patient with anti-TNF-α treatment
31. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent
32. Complement receptor-mediated uptake and TNF-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages
33. Tumor necrosis factor α (TNFα) promotes growth of virulent Mycobacterium tuberculosis in human monocytes: Iron-mediated growth suppression is correlated with decreased release of TNFα from iron-treated infected monocytes
34. Induction of direct antimicrobial activity through mammalian toll-like receptors
35. Antibody-mediated inhibition of primary antibody formation in vivo and vitro in NZB mice
36. An isotype incorporation assay for the antimycobacterial effects of human monocytes
37. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis
38. Activation of human dendritic cells following infection with Mycobacterium tuberculosis
39. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response
40. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis
41. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α
42. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages
43. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis
44. Increased TNF-α, IL-1β and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis
45. In situ production of γ interferon, interleukin-4, and tumor necrosis factor a mRNA in human lung tuberculous granulomas
46. Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis
47. A macrophage invasion mechanism of pathogenic mycobacteria
48. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages
49. Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus
50. CD14 is a pattern recognition receptor
51. A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43
52. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules
53. Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis
54. Separation of alveolar macrophages and dendritic cells via autofluorescence: Phenotypical and functional characterization
55. Monocyte-derived macrophage cytokine responses induced by M. bovis BCG
56. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
57. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria
58. The role of γ-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis
59. Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of tumor necrosis factor α but not with evasion of lymphocyte-dependent monocyte effector functions
60. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
61. Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system
62. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene
63. Iron acquisition and metabolism by mycobacteria
64. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor
65. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10
66. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions
67. The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor
68. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin
69. + T lymphocytes in intracellular microbial infections
70. Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
71. Tumor necrosis factor: A master-regulator of leukocyte movement
72. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis
73. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
74. Growth inhibition of Mycobacterium bovis by IFN-γ stimulated macrophages: Regulation by endogenous tumor necrosis factor-α and by IL-10
75. Confrontation between intracellular bacteria and the immune system